Dr. Larry L. Schlabach, MD

  • Chattanooga, TN
  • Medical oncologist
NPI1386609394PAC ID9830093822
Medicare services, 2024
1,798
Medicare patients, 2024
156
Part D claims, 2024
528
Publications
1
Clinical trials
5
Practice address
975 E 3rd St, Chattanooga, TN 37403
Practice phone
Call (423) 778-7000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Erlanger Baroness Hospital

Hospital · Chattanooga, Tennessee

See all 5 affiliations

Find Dr. Schlabach's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Larry L. Schlabach is a medical oncologist in Chattanooga, Tennessee

Dr. Schlabach practices at Erlanger Baroness Hospital in Chattanooga, Tennessee, part of Erlanger Health.

Dr. Schlabach's NPI, 1386609394, was assigned on April 20, 2006. Dr. Schlabach graduated from Wright State University Boonshoft School of Medicine in 1987. Dr. Schlabach holds Tennessee license MD00019043.

NPI and contact details
Medicare PAC ID
9830093822
NPI enumeration date
April 20, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(423) 778-7000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
65
Medical school graduation
1987

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Larry L. Schlabach practices at Erlanger Baroness Hospital in Chattanooga, Tennessee

Dr. Schlabach's primary practice is Erlanger Baroness Hospital, at 975 E 3rd St, Chattanooga, TN 37403 in Hamilton County. The practice phone is (423) 778-7000.

Source: Dmand AI Affiliation Data

Dr. Larry L. Schlabach is affiliated with 4 sites of care and 1 medical group

Dr. Schlabach's primary practice is Erlanger Baroness Hospital in Chattanooga, Tennessee, part of Erlanger Health. Dr. Schlabach is also affiliated with CommonSpirit - Memorial Hospital - Chattanooga. The medical group on file is Tennessee Oncology. Dmand AI also links Dr. Schlabach to 1 more community health center and 1 group practice or clinic, each named with a free account.

See all 5 affiliations for Dr. Schlabach

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Larry L. Schlabach's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schlabach practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Erlanger Baroness HospitalAvailable with a free account
+3 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Schlabach practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Erlanger Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Larry L. Schlabach is one of 99 medical oncologists in Tennessee

Medical oncology is Dr. Schlabach's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Schlabach is licensed in Tennessee.

Specialties and state licenses

  • Medical oncology, TennesseePrimaryLicense MD00019043 · taxonomy 207RX0202X

Medical oncologists near Dr. Schlabach

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Larry L. Schlabach billed Medicare for 1,798 services in 2024

CMS data shows 1,798 Medicare services from Dr. Schlabach across 21 procedure codes in 2024, for 156 Medicare patients. Medicare paid $36,131 for them. Every service was in an office.

Medicare services, 20241,798
Medicare patients156
Paid by Medicare$36,131
Procedure codes21

Dr. Schlabach's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Lab and pathology
2023: 5312024: 67828%
Drugs given in the office
2023: 16,3552024: 42097%
Surgery
2023: 1702024: 24745%
Office and hospital visits
2023: 1702024: 22231%
Tests and treatments
2023: 3182024: 15751%
Other services
2023: 02024: 74

Dr. Schlabach compared with the Tennessee median for medical oncologists, 2024

  • Dr. Schlabach
  • Tennessee median
Medicare services
1,798vs 1,19451% above
Medicare patients
156vs 23433% below
Part D claims
365vs 370Close to median

Medians across 94 medical oncologists in Tennessee with Dmand AI profiles that report each measure.

Dr. Schlabach's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Schlabach

Need commercial claims for Dr. Schlabach?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Schlabach and other medical oncologists in Tennessee.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Larry L. Schlabach treated 156 Medicare patients in 2024, average age 75

CMS counts 156 Medicare patients who saw Dr. Schlabach in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schlabach's median patient age at 66, with 64% women.

Medicare patients, 2024156
Average age75
Average risk score1.87
Also on Medicaid8%

Dr. Schlabach's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Schlabach's Medicare patients by sex, 2024

  • Women9360%
  • Men6340%

Chronic conditions among Dr. Schlabach's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol68%
  3. Arthritis54%
  4. Cancer49%
  5. Diabetes37%
  6. Chronic kidney disease35%
  7. Anxiety32%
  8. Ischemic heart disease31%

Share of Medicare patients with each condition. A patient can have several.

Dr. Schlabach's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 66

Patient panel by sex, all payers

  • Women64%
  • Men36%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Larry L. Schlabach wrote 528 Medicare Part D claims in 2024

In 2024, Dr. Schlabach wrote 528 Medicare Part D claims for 83 patients. 81% of them were for generic drugs. CMS names the drug for 365 of them, across 14 drugs with 11 or more claims each, at $142,388 in total drug cost. In 2023, CMS named 257 claims across 15 drugs.

Part D claims, 2024528
Drugs named by CMS14
Total drug cost$142,388
Part D patients83

Dr. Schlabach's Part D claims by kind of drug, 2024

  • Generic428 claims81%
  • Brand-name100 claims19%

Dr. Schlabach's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Schlabach's Part D claims, 2024

  • Opioids7%38 of 528 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2572024: 36542%

Drugs named by CMS: 14 in 2024, 15 in 2023.

See all prescribing by Dr. Schlabach

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Larry L. Schlabach scored 93 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Schlabach for performance year 2024, reported as part of a group. Dr. Schlabach accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Schlabach's MIPS scores, performance year 2024

  • 93of 100Final score
  • 89of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Schlabach by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Larry L. Schlabach has 1 publication on record

Dmand AI links 1 paper to Dr. Schlabach in 2014. Dr. Schlabach's most frequent co-authors are Russell Foster Devore, MD, Laura Williams Goff, MD and Charles F. Winkler, MD.

Papers1

Dr. Schlabach's most frequent co-authors

Recent publications by Dr. Schlabach

See all 1 publications and co-authors

See who Dr. Schlabach researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Schlabach works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Larry L. Schlabach has worked on 5 clinical trials

Dmand AI links Dr. Schlabach to 5 clinical trials, 4 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Neoplasms, Male and Leukemia, Megakaryoblastic, Acute. SWOG Cancer Research Network sponsors the most, 2. Open Payments lists research payments to Dr. Schlabach that name 1 trial.

Conditions in Dr. Schlabach's trials

  • Breast Neoplasms
  • Breast Neoplasms, Male
  • Leukemia, Megakaryoblastic, Acute
  • Melanoma
  • Prostatic Neoplasms

Investigators on the most trials with Dr. Schlabach

Recent clinical trials with Dr. Schlabach

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Larry L. Schlabach received $572 in industry payments from 2018 to 2025

CMS Open Payments shows 24 general payments to Dr. Schlabach from 15 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 69% of the total. Janssen Pharmaceuticals, Inc paid the most, $114. It also lists 1 research payment totaling $450 in 2018, naming 1 clinical trial.

General payments to Dr. Schlabach by program year, 2018 to 2025

General payments to Dr. Schlabach by kind, 2018 to 2025

$572in total
  • Food and beverage$39769%
  • Education$17531%

Companies that paid Dr. Schlabach the most, 2018 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Schlabach

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Larry L. Schlabach graduated from Wright State University Boonshoft School of Medicine

Dr. Schlabach graduated from Wright State University Boonshoft School of Medicine in 1987.

  1. Medical schoolWright State University Boonshoft School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Larry L. Schlabach's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Larry L. Schlabach

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Larry L. Schlabach's NPI number?

Dr. Larry L. Schlabach's NPI number is 1386609394. It was assigned on April 20, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Larry L. Schlabach?

Dr. Larry L. Schlabach is a medical oncologist in Chattanooga, Tennessee. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Larry L. Schlabach practice?

Dr. Schlabach practices at 975 E 3rd St, Chattanooga, TN 37403. Dr. Schlabach's primary practice is Erlanger Baroness Hospital in Chattanooga, Tennessee, part of Erlanger Health. Dmand AI also links Dr. Schlabach to 1 community health center and 1 group practice or clinic.

What is Dr. Larry L. Schlabach's office phone number?

The practice phone on file for Dr. Schlabach is (423) 778-7000.

What is Dr. Larry L. Schlabach's medical license number?

Dr. Schlabach holds Tennessee license MD00019043.

Which hospitals is Dr. Larry L. Schlabach affiliated with?

Dr. Schlabach practices at Erlanger Baroness Hospital in Chattanooga, Tennessee. Dr. Schlabach is also affiliated with CommonSpirit - Memorial Hospital - Chattanooga.

What medical group is Dr. Larry L. Schlabach part of?

Dr. Schlabach is linked to Tennessee Oncology.

Does Dr. Larry L. Schlabach accept Medicare?

Yes. CMS data shows Dr. Schlabach billed Medicare for 1,798 services in 2024, and Dr. Schlabach accepts Medicare assignment.

What is Dr. Larry L. Schlabach's MIPS score?

Dr. Schlabach's MIPS final score for performance year 2024 is 93 out of 100, reported as part of a group.

How many Medicare patients does Dr. Larry L. Schlabach see?

CMS counts 156 Medicare patients who saw Dr. Schlabach in 2024, with an average age of 75.

Show 7 more questionsShow fewer questions

What services does Dr. Larry L. Schlabach bill to Medicare?

In 2024, Dr. Schlabach's most billed Medicare services were injected or infused drug (J1100), lab and pathology test (85025) and surgery: heart and blood vessels (36415).

Where did Dr. Larry L. Schlabach go to medical school?

Dr. Schlabach graduated from Wright State University Boonshoft School of Medicine in 1987.

What drugs does Dr. Larry L. Schlabach prescribe most?

In 2024 Medicare Part D data, Dr. Schlabach's most prescribed drugs by claims were Anastrozole, Abiraterone Acetate and Prednisone.

Has Dr. Larry L. Schlabach received payments from drug or device companies?

CMS Open Payments shows $572 in general payments to Dr. Schlabach from 15 companies from 2018 to 2025. The largest total came from Janssen Pharmaceuticals, Inc.

How long has Dr. Larry L. Schlabach been practicing?

Dr. Schlabach graduated from medical school in 1987, 39 years ago.

Does Dr. Larry L. Schlabach do research?

Dmand AI links 1 publication to Dr. Schlabach. Dr. Schlabach has worked on 5 clinical trials.

Who does Dr. Larry L. Schlabach publish with?

Dr. Schlabach's most frequent co-authors are Russell Foster Devore, MD (1 shared paper), Laura Williams Goff, MD (1 shared paper) and Charles F. Winkler, MD (1 shared paper).

Selling to medical oncology practices?

See medical oncologists in Tennessee by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)